Tetrac as an Anti-Angiogenic Agent in Cancer

Endocrine-Related Cancer - United Kingdom
doi 10.1530/erc-19-0058
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Inhibition of Lymph Node Metastasis by an Anti-Angiogenic Agent, TNP-470

British Journal of Cancer
Cancer ResearchOncology
1997English

The Warburg Effect in Endothelial Cells and Its Potential as an Anti-Angiogenic Target in Cancer

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2018English

Anti‐angiogenic Therapies for Gastric Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Kojic Acid as an Anti-Speck Agent.

Agricultural and Biological Chemistry
1988English

Largazole as a Novel and Selective Anti-Breast Cancer Agent

2011English

Alginate Hydrogel Improves Anti-Angiogenic Bevacizumab Activity in Cancer Therapy

European Journal of Pharmaceutics and Biopharmaceutics
MedicineBiotechnologyPharmaceutical Science
2017English

T-Oligo as an Anticancer Agent in Colorectal Cancer

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2014English

Hypertension in Cancer Patients Treated With Anti-Angiogenic Based Regimens

Cardio-Oncology
2015English

Mechanism Study of Isoflavones as an Anti-Retinoblastoma Progression Agent

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy